MHRA

News

UK first to approve Vertex, CRISPR drug for blood disorders

The first-ever CRISPR-based gene-editing therapy has been approved for marketing in the UK for inherited blood disorders sickle cell disease (SCD) and transfusion-dependen

Sales & Marketing

12 Questions with Andrea Manfrin

Professor Andrea Manfrin joined the MHRA in June 2023 as Deputy Director of Clinical Investigations and Trials, to spearhead the regulator’s overhaul of the clinical trial regulations.

News

MHRA pledges two-week review for low-risk clinical trials

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has implemented one part of its plan to reform the regulations governing clinical trials, namely an ini

News

MHRA unveils big shakeup in UK clinical trials regs

Reforms will make applications streamlined and flexible without affecting safety, says agency.

News

Tributes as former NICE, MHRA chair Sir Mike Rawlins dies

The UK healthcare sector is mourning one of the most eminent of its figures in the last few decades – Professor Sir Mike Rawlins – who has passed away at the age of 81.

News